Redefining surveillance strategies: innovations in testicular cancer care.
作者信息
Chavarriaga Julian, Sayyid Rashid K, Bernardino Rui, Kumar Ravi, Al-Rumayyan Majed, Hamilton Robert J
机构信息
Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
出版信息
Transl Androl Urol. 2023 Sep 30;12(9):1368-1370. doi: 10.21037/tau-23-391. Epub 2023 Aug 31.
Abstract
摘要
相似文献
1
Redefining surveillance strategies: innovations in testicular cancer care.重新定义监测策略：睾丸癌护理的创新
Transl Androl Urol. 2023 Sep 30;12(9):1368-1370. doi: 10.21037/tau-23-391. Epub 2023 Aug 31.
2
Novel approaches to redesign surveillance strategies following orchiectomy for localized testicular cancer: a narrative review.睾丸局部切除术后重新设计监测策略的新方法：一项叙述性综述
Transl Androl Urol. 2023 Jun 30;12(6):1016-1022. doi: 10.21037/tau-22-855. Epub 2023 May 24.
3
Feasibility of active surveillance in small testicular mass: a mini review.小睾丸肿块主动监测的可行性：一篇综述
Cent European J Urol. 2021;74(1):10-13. doi: 10.5173/ceju.2021.0268. Epub 2021 Feb 4.
4
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy.当代 I 期睾丸精原细胞瘤生存率评估：睾丸切除术 后监测与主动治疗的人群比较。
Clin Genitourin Cancer. 2019 Aug;17(4):e793-e801. doi: 10.1016/j.clgc.2019.04.015. Epub 2019 Apr 30.
5
How has early testicular cancer affected your life? A study of sexual function in men attending active surveillance for stage one testicular cancer.早期睾丸癌对你的生活有何影响？一项针对接受一期睾丸癌主动监测男性性功能的研究。
Eur J Oncol Nurs. 2015 Jun;19(3):278-81. doi: 10.1016/j.ejon.2014.11.001. Epub 2014 Dec 13.
6
Testicular microlithiasis: is there a need for surveillance in the absence of other risk factors?睾丸微石症：在没有其他危险因素的情况下是否需要进行监测？
Eur Radiol. 2012 Nov;22(11):2540-6. doi: 10.1007/s00330-012-2520-4. Epub 2012 Jun 19.
7
The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance.早期睾丸癌患者从积极治疗过渡到随访监测期间的经历。
Urol Oncol. 2016 Apr;34(4):168.e11-20. doi: 10.1016/j.urolonc.2015.09.016. Epub 2015 Dec 18.
8
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).睾丸癌患者的基线特征与护理模式：来自瑞士-奥地利-德国睾丸癌队列研究（SAG TCCS）的首批数据。
Swiss Med Wkly. 2018 Jul 24;148:w14640. doi: 10.4414/smw.2018.14640. eCollection 2018.
9
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.临床Ⅰ期睾丸癌监测中的复发条件风险。
Eur Urol. 2017 Jan;71(1):120-127. doi: 10.1016/j.eururo.2016.07.013. Epub 2016 Aug 12.
10
Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005.1970 年至 2005 年期间，7 个欧洲国家 5 种癌症的医疗保健创新和死亡率趋势。
Int J Public Health. 2014 Apr;59(2):341-50. doi: 10.1007/s00038-013-0507-9. Epub 2013 Aug 29.
本文引用的文献
1
Novel approaches to redesign surveillance strategies following orchiectomy for localized testicular cancer: a narrative review.睾丸局部切除术后重新设计监测策略的新方法：一项叙述性综述
Transl Androl Urol. 2023 Jun 30;12(6):1016-1022. doi: 10.21037/tau-22-855. Epub 2023 May 24.
2
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.临床I期睾丸生殖细胞肿瘤主动监测中减少随访强度的安全性
Eur Urol Open Sci. 2022 Apr 27;40:46-53. doi: 10.1016/j.euros.2022.03.010. eCollection 2022 Jun.
3
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).影像学检查方法和频率在 I 期精原细胞瘤睾丸生殖细胞肿瘤监测中的应用：来自一项随机、III 期、非劣效性试验（TRISST）的结果。
J Clin Oncol. 2022 Aug 1;40(22):2468-2478. doi: 10.1200/JCO.21.01199. Epub 2022 Mar 17.
4
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.血清 miR-371a-3p 在预测临床Ⅰ期睾丸生殖细胞癌患者监测复发中的应用。
Eur Urol Oncol. 2021 Jun;4(3):483-491. doi: 10.1016/j.euo.2020.11.004. Epub 2020 Dec 4.
5
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.血清 microRNA-371a-3p（M371 检测）作为睾丸生殖细胞肿瘤的新型生物标志物：一项前瞻性多中心研究的结果。
J Clin Oncol. 2019 Jun 1;37(16):1412-1423. doi: 10.1200/JCO.18.01480. Epub 2019 Mar 15.
6
Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.基于人群的队列研究：Ⅰ期非精原细胞瘤睾丸生殖细胞肿瘤的监测：结果和长期随访。
J Clin Oncol. 2014 Dec 1;32(34):3817-23. doi: 10.1200/JCO.2013.53.5831. Epub 2014 Sep 29.
7
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.临床Ⅰ期睾丸生殖细胞肿瘤主动监测患者复发模式。
J Clin Oncol. 2015 Jan 1;33(1):51-7. doi: 10.1200/JCO.2014.56.2116. Epub 2014 Aug 18.
8
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.临床 I 期非精原细胞瘤生殖细胞肿瘤的非风险适应监测：玛嘉烈公主医院的经验。
Eur Urol. 2011 Apr;59(4):556-62. doi: 10.1016/j.eururo.2010.12.010. Epub 2010 Dec 22.
Zotero 插件